Link: https://en.wikipedia.org/wiki/Pimavanserin
Description: WebPimavanserin, sold under the brand name Nuplazid, is an atypical antipsychotic which is approved for the treatment of Parkinson's disease psychosis and is also being studied for the treatment of Alzheimer's disease psychosis, schizophrenia, agitation, and major depressive disorder.
DA: 60 PA: 9 MOZ Rank: 55
Link: https://www.ncbi.nlm.nih.gov/books/NBK557712/
Description: WebMay 1, 2023 · Pimavanserin is a medication used to treat and manage the hallucinations and delusions associated with Parkinson disease psychosis. It is in the atypical antipsychotic class of drugs. This activity reviews the indication, action, and contraindications for pimavanserin as a valuable agent in managing Parkinson disease psychosis.
DA: 14 PA: 9 MOZ Rank: 15
Link: https://www.nuplazid.com/
Description: WebParkinson's-Related Hallucinations and Delusions Treatment | NUPLAZID® (pimavanserin) A dedicated Care Coordinator will assist you with accessing and affording your medication. NUPLAZID ® is an FDA-approved treatment for hallucinations and delusions associated with Parkinson's disease psychosis.
DA: 29 PA: 72 MOZ Rank: 61
Link: https://www.drugs.com/mtm/pimavanserin.html
Description: WebAug 16, 2023 · What is pimavanserin? Pimavanserin is an antipsychotic medicine that works by changing the actions of chemicals in the brain. Pimavanserin is used to treat hallucinations and delusions caused by psychosis that is related to Parkinson's disease. Pimavanserin may also be used for purposes not listed in this medication guide.
DA: 66 PA: 45 MOZ Rank: 94
Link: https://www.fda.gov/news-events/press-announcements/fda-approves-first-drug-treat-hallucinations-and-delusions-associated-parkinsons-disease
Description: WebApril 29, 2016. The U.S. Food and Drug Administration today approved Nuplazid (pimavanserin) tablets, the first drug approved to treat hallucinations and delusions associated with psychosis...
DA: 10 PA: 61 MOZ Rank: 5
Link: https://www.mayoclinic.org/drugs-supplements/pimavanserin-oral-route/description/drg-20311664
Description: WebDescriptions. Pimavanserin is used to treat hallucinations and delusions caused by Parkinson disease psychosis. It works in the brain to prevent hallucinations and delusions. Pimavanserin should not be used to treat behavioral problems in …
DA: 95 PA: 36 MOZ Rank: 11
Link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10239266/
Description: WebMay 30, 2023 · Medical treatment is limited to few atypical antipsychotic drugs with low affinity to dopamine D2 receptors. In 2016, pimavanserin, a selective 5-HT2A inverse agonist/antagonist, was approved by the US Food and Drug Administration (FDA) as the only treatment for PD psychosis (PDP).
DA: 63 PA: 90 MOZ Rank: 59
Link: https://go.drugbank.com/drugs/DB05316
Description: WebPimavanserin is a second generation atypical antipsychotic used for the treatment of hallucinations and delusions caused by Parkinson's Disease. Brand Names. Nuplazid. Generic Name. Pimavanserin. DrugBank Accession Number. DB05316. Background.
DA: 58 PA: 93 MOZ Rank: 69
Link: https://www.webmd.com/drugs/2/drug-171730/pimavanserin-oral/details
Description: WebThis medication is used to treat the symptoms of a certain mental/ mood disorder ( psychosis) that might occur with Parkinson's disease. Pimavanserin belongs to a class of drugs known as atypical...
DA: 69 PA: 55 MOZ Rank: 48
Link: https://medlineplus.gov/druginfo/meds/a616032.html
Description: WebPimavanserin is used to treat hallucinations and delusions in people with psychosis from Parkinson's disease (PD; a disorder of the nervous system that causes difficulties with movement, muscle control, and balance). Pimavanserin is in a class of medications called atypical antipsychotics.
DA: 53 PA: 13 MOZ Rank: 66
